International Projects

Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risk evaluation and model development (REfraME)
Program: H2020-EU.3.1, Ref No.: 643417
Project Coordinator: Giuseppe Legname, SISSA, Trieste, Italy
Duration: Jan 1, 2015 – Dec 31, 2018
Participating investigators:
  • A. Aguzzi (University of Zurich),
  • M. Goedert (MRC Laboratory of Molecular Biology, UK),
  • M. Jucker (DZNE, Germany),
  • G. Di Fede (IRCCS Foundation Carlo Besta Neurological Institute, Italy),
  • J-Y. Li (Lund University, Sweden)
  • M. Novak (NIU, Slovakia)
REfraME countries
SyDAD Synaptic Dysfunction in Alzheimer Disease
Program: H2020-EU.1.3.1., Ref No.: 676144
Project Coordinator: Bengt Winblad, KAROLINSKA INSTITUTET, Sweden
Duration: Nov 1, 2015 – Oct 31, 2019
SyDAD countries
Repetitive Subconcussive Head Impacts -Brain Alterations and Clinical Consequences
Program: ERANET
Project Coordinator: Inga Katharina Koerte, MD PhD, Ludwig-Maximilians-Universität München, Department of Child and Adolescent Psychiatry, Psychosomatics, Germany
Project Co-investigator: Assoc. Prof. Peter Filipcik, RNDr, PhD
Duration: January 1, 2017 – 31 December 2019
ERANET
 

Non-globular proteins in the era of Machine Learning
Program: COST
Project leader: Ing. Cehlár Ondrej, PhD.
Duration: 1.10.2022 – 31.10.2026
A premotor disease signature for ALS
premodiALS – Rukopis pre-motorického štádia amytrofnej laterálnej sklerózy
Program: Horizon 2020
Project leader: doc. MVDr. Žilka Norbert, DrSc.
Duration: 1.9.2022 – 31.8.2025
Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs
INTERTAU – Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs
Program: Horizon 2020
Project leader: RNDr. Škrabana Rostislav, PhD.
Duration: 1.6.2022 – 30.6.2025
Developing novel nanopharmaceutics against bacterial infections at center nervous system
Antineuropatho – Vývoj nových nanoliečiv proti bakteriálnym infekciám v centrálnom nervovom systéme
Program: ERANET
Project leader: doc. MVDr. Bhide Mangesh Ramesh, PhD.
Duration: 1.1.2022 – 31.12.2024